Insider Transactions in Q1 2024 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 18
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
46,465,458
+46.24%
|
$92,930,916
$2.75 P/Share
|
Mar 05
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Direct |
1,403
+0.01%
|
$2,806
$2.62 P/Share
|
Mar 04
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Direct |
250,000
+2.13%
|
$500,000
$2.57 P/Share
|
Feb 20
2024
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
22,800
+18.04%
|
$45,600
$2.5 P/Share
|
Jan 05
2024
|
Michael Egholm President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,006
+3.84%
|
-
|
Jan 05
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,744,219
+50.0%
|
-
|
Jan 05
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,246,525
+50.0%
|
-
|
Jan 05
2024
|
Kathy L Hibbs |
BUY
Grant, award, or other acquisition
|
Direct |
79,412
+50.0%
|
-
|
Jan 05
2024
|
Thomas D. Carey |
BUY
Grant, award, or other acquisition
|
Direct |
79,412
+50.0%
|
-
|
Jan 05
2024
|
Troy Cox |
BUY
Grant, award, or other acquisition
|
Direct |
198,104
+32.02%
|
-
|
Jan 05
2024
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Indirect |
21,538,744
+50.0%
|
-
|
Jan 05
2024
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
7,614
+4.61%
|
-
|